Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Novartis AG · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $69.81B | $68.32B - $72.34B | $31.44B | $12.589 | 6 |
| Dec 2029 | $66.93B | $65.51B - $69.36B | $30.15B | $11.667 | 12 |
| Dec 2028 | $64.10B | $62.74B - $66.43B | $28.87B | $10.757 | 8 |
| Dec 2027 | $60.22B | $59.29B - $62.07B | $27.12B | $9.751 | 13 |
| Dec 2026 | $56.76B | $56.24B - $58.44B | $25.57B | $8.745 | 12 |
| Dec 2025 | $55.47B | $53.33B - $56.26B | $24.98B | $8.927 | 13 |
| Dec 2024 | $50.44B | $50.04B - $51.18B | $22.72B | $7.539 | 11 |
| Dec 2023 | $46.80B | $42.11B - $53.07B | $37.93B | $6.669 | 14 |
| Dec 2022 | $51.52B | $50.34B - $52.66B | $34.48B | $5.699 | 3 |
| Dec 2021 | $52.09B | $50.89B - $53.25B | $33.19B | $5.96 | 4 |
| Dec 2020 | $49.25B | $48.12B - $50.34B | $16.31B | $5.491 | 4 |
| Dec 2019 | $48.00B | $46.90B - $49.07B | $18.96B | $5.006 | 3 |